HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Previous close
$0.033
Year range
$0.033 - $0.078
Market cap
4.77M AUD
Avg Volume
31.87K
P/E ratio
14.73
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.11M | -41.71% |
Operating expense | 361.34K | -59.93% |
Net income | 777.18K | -21.94% |
Net profit margin | 70.28 | 33.92% |
Earnings per share | — | — |
EBITDA | 757.79K | -23.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.95M | 0.86% |
Total assets | 5.44M | 2.74% |
Total liabilities | 85.68K | -85.66% |
Total equity | 5.35M | — |
Shares outstanding | 144.60M | — |
Price to book | 0.83 | — |
Return on assets | 33.73% | — |
Return on capital | 34.27% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 777.18K | -21.94% |
Cash from operations | 808.83K | 2.01% |
Cash from investing | 0.00 | — |
Cash from financing | — | — |
Net change in cash | 808.83K | 2.01% |
Free cash flow | 496.36K | -18.41% |
About
Founded
2002
Website
